Moreover, the 36-month beta value for XRAY is 0.96. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 4 as “overweight,” 10 as “hold,” and 0 as “sell.”
The public float for XRAY is 197.55M and currently, short sellers hold a 4.38% of that float. On February 05, 2025, XRAY’s average trading volume was 3.36M shares.
XRAY) stock’s latest price update
DENTSPLY Sirona Inc (NASDAQ: XRAY) has seen a decline in its stock price by -0.31 in relation to its previous close of 19.35. However, the company has experienced a -1.68% decline in its stock price over the last five trading sessions. accessnewswire.com reported 2025-02-02 that NEW YORK, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/XRAY.
XRAY’s Market Performance
XRAY’s stock has fallen by -1.68% in the past week, with a monthly rise of 2.88% and a quarterly drop of -16.75%. The volatility ratio for the week is 2.62% while the volatility levels for the last 30 days are 3.28% for DENTSPLY Sirona Inc The simple moving average for the last 20 days is 1.14% for XRAY stock, with a simple moving average of -19.63% for the last 200 days.
Analysts’ Opinion of XRAY
Many brokerage firms have already submitted their reports for XRAY stocks, with Jefferies repeating the rating for XRAY by listing it as a “Hold.” The predicted price for XRAY in the upcoming period, according to Jefferies is $20 based on the research report published on January 23, 2025 of the current year 2025.
Evercore ISI, on the other hand, stated in their research note that they expect to see XRAY reach a price target of $20. The rating they have provided for XRAY stocks is “In-line” according to the report published on January 07th, 2025.
Mizuho gave a rating of “Neutral” to XRAY, setting the target price at $21 in the report published on December 04th of the previous year.
XRAY Trading at 0.80% from the 50-Day Moving Average
After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.74% of loss for the given period.
Volatility was left at 3.28%, however, over the last 30 days, the volatility rate increased by 2.62%, as shares surge +3.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.17% upper at present.
During the last 5 trading sessions, XRAY fell by -1.68%, which changed the moving average for the period of 200-days by -36.46% in comparison to the 20-day moving average, which settled at $19.07. In addition, DENTSPLY Sirona Inc saw 1.63% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XRAY starting from Coleman Glenn, who proposed sale 15,759 shares at the price of $19.75 back on Jan 27 ’25. After this action, Coleman Glenn now owns shares of DENTSPLY Sirona Inc, valued at $311,240 using the latest closing price.
LUCIER GREGORY T, the Director of DENTSPLY Sirona Inc, purchase 5,000 shares at $18.37 during a trade that took place back on Nov 18 ’24, which means that LUCIER GREGORY T is holding 71,730 shares at $91,850 based on the most recent closing price.
Stock Fundamentals for XRAY
Current profitability levels for the company are sitting at:
- -0.07 for the present operating margin
- 0.52 for the gross margin
The net margin for DENTSPLY Sirona Inc stands at -0.11. The total capital return value is set at -0.05. Equity return is now at value -14.08, with -5.97 for asset returns.
Based on DENTSPLY Sirona Inc (XRAY), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.23. The debt to equity ratio resting at 0.93. The interest coverage ratio of the stock is -3.61.
Currently, EBITDA for the company is 232.0 million with net debt to EBITDA at 25.95. When we switch over and look at the enterprise to sales, we see a ratio of 1.5. The receivables turnover for the company is 5.81for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.25.
Conclusion
To wrap up, the performance of DENTSPLY Sirona Inc (XRAY) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
